To better understand the etiology and pathomechanisms of Alzheimer’s disease, several transgenic animal models that overexpress human tau or human amyloid-beta (Aβ) have been developed. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.